|
Changes in mRNA expression levels of metabolism-related genes in HepG2-tet-off-hPPAR cells by ligands. Microarray analyses were performed on HepG2-tet-off-hPPAR cells; the cells were cultured in the presence (Dox) or absence of Dox for 5 days. In the absence of Dox, the cells were treated with PPAR ligands (100 μM fenofibric acid for PPARα (Feno), 100 nM GW501516 for PPARδ (GW) or 10 μM ciglitizone for PPARγ (Cig)) or vehicle (DMSO) for 24 h. Gene expression profiles were compared between DMSO and Dox (DMSO versus Dox), ligands and Dox (Feno versus Dox, GW versus Dox, and Cig versus Dox were indicated in the case of PPARα, PPARδ and PPARγ, respectively) or ligands and DMSO (Feno versus DMSO, GW versus DMSO, and Cig versus DMSO were indicated in the case of PPARα, PPARδ and PPARγ, respectively). Samples were analysed using GeneChip® software Microarray Suite (MAS) Ver.5.0 (Affymetrix). |
|||||||||||||
| Gene |
Genbank accession No. |
PPARα |
PPARδ |
PPARγ1 |
PPARγ2 |
||||||||
|
|
|||||||||||||
| Fold change |
Fold change |
Fold change |
Fold change |
||||||||||
|
|
|||||||||||||
| DMSO vs. Dox |
Feno vs. Dox |
Feno vs. DMSO |
DMSO vs. Dox |
GW vs. Dox |
GW vs. DMSO |
DMSO vs. Dox |
Cig vs. Dox |
Cig vs. DMSO |
DMSO vs. Dox |
Cig vs. Dox |
Cig vs. DMSO |
||
|
|
|||||||||||||
| Fatty acid metabolism |
|||||||||||||
| acyl-CoA synthetase long-chain family member 1 |
NM_001995 |
1.84 |
3.49 |
1.90 |
0.82 |
1.72 |
2.09 |
0.88 |
2.30 |
2.60 |
0.82 |
1.00 |
1.23 |
| carnitine palmitoyltransferase 1A (liver) |
NM_001876 |
1.48 |
2.86 |
1.93 |
0.37 |
2.05 |
5.60 |
0.74 |
1.35 |
1.83 |
1.12 |
1.24 |
1.10 |
| solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
NM_000387 |
1.20 |
2.23 |
1.85 |
0.91 |
1.36 |
1.50 |
0.83 |
0.93 |
1.12 |
1.04 |
1.27 |
1.22 |
| acyl-Coenzyme A dehydrogenase, very long chain |
NM_000018 |
2.16 |
3.46 |
1.60 |
0.92 |
2.69 |
2.93 |
1.36 |
1.97 |
1.45 |
1.55 |
2.33 |
1.50 |
| acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain |
NM_000016 |
1.62 |
2.52 |
1.56 |
0.64 |
2.03 |
3.16 |
1.24 |
1.48 |
1.20 |
1.40 |
1.80 |
1.29 |
| hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit |
NM_000182 |
1.48 |
2.43 |
1.65 |
0.89 |
1.49 |
1.66 |
1.34 |
1.62 |
1.21 |
1.41 |
2.29 |
1.62 |
| hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit |
NM_000183 |
1.74 |
2.66 |
1.53 |
0.95 |
1.30 |
1.36 |
1.17 |
1.49 |
1.27 |
1.14 |
1.62 |
1.42 |
| acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) |
NM_006111 |
1.58 |
1.92 |
1.21 |
1.06 |
1.63 |
1.53 |
0.89 |
1.31 |
1.47 |
1.18 |
2.44 |
2.06 |
| acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiolase) |
NM_001607 |
1.42 |
1.62 |
1.14 |
0.68 |
1.47 |
2.15 |
1.22 |
2.07 |
1.70 |
1.42 |
2.01 |
1.41 |
| enoyl Coenzyme A hydratase 1, peroxisomal |
NM_001398 |
2.28 |
2.61 |
1.15 |
0.99 |
2.05 |
2.07 |
1.16 |
1.46 |
1.26 |
1.44 |
1.98 |
1.38 |
| Antioxidant |
|||||||||||||
| catalase |
NM_001752 |
1.51 |
2.36 |
1.56 |
0.68 |
1.45 |
2.13 |
1.06 |
1.54 |
1.45 |
1.69 |
2.59 |
1.53 |
| vanin 1 |
NM_004666 |
5.07 |
12.92 |
2.55 |
0.68 |
1.91 |
2.80 |
2.42 |
6.02 |
2.49 |
1.77 |
5.70 |
3.23 |
| Ketogenesis |
|||||||||||||
| 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) |
NM_005518 |
32.40 |
156.62 |
4.83 |
1.13 |
2.51 |
2.22 |
2.14 |
6.57 |
3.07 |
2.20 |
6.53 |
2.96 |
| Transport/strage |
|||||||||||||
| fatty acid binding protein 1, liver |
NM_001443 |
1.39 |
2.08 |
1.50 |
0.18 |
1.33 |
7.57 |
2.73 |
6.52 |
2.39 |
3.52 |
10.44 |
2.96 |
| adipose differentiation-related protein |
NM_001122 |
1.96 |
3.44 |
1.75 |
0.22 |
2.90 |
13.02 |
3.33 |
6.06 |
1.82 |
3.40 |
5.73 |
1.68 |
| C-terminal linking and modulating protein/PDZ domain containing 1 |
NM_002614 |
2.16 |
3.02 |
1.40 |
0.52 |
2.85 |
5.45 |
1.03 |
2.42 |
2.34 |
1.98 |
3.21 |
1.62 |
| lipase, hepatic |
NM_000236 |
8.34 |
10.39 |
1.25 |
0.72 |
2.89 |
4.00 |
1.08 |
2.47 |
2.28 |
1.64 |
3.99 |
2.44 |
| Gluconeogenesis |
|||||||||||||
| aquaporin 3 |
NM_004925 |
3.00 |
5.86 |
1.95 |
0.26 |
1.91 |
7.38 |
1.58 |
3.41 |
2.16 |
1.38 |
3.09 |
2.24 |
| glycerol kinase |
NM_000167 |
0.87 |
1.57 |
1.79 |
0.73 |
0.79 |
1.08 |
1.00 |
1.21 |
1.21 |
1.84 |
3.17 |
1.73 |
| phosphoenolpyruvate carboxykinase 1 (soluble) |
NM_002591 |
6.39 |
17.90 |
2.80 |
0.83 |
4.64 |
5.56 |
6.94 |
29.19 |
4.20 |
34.46 |
110.78 |
3.21 |
| Metabolism |
|||||||||||||
| angiopoietin-like protein 4 |
NM_016109 |
1.71 |
17.97 |
10.54 |
3.00 |
25.67 |
8.56 |
1.24 |
7.27 |
5.84 |
3.88 |
33.56 |
8.66 |
| heme oxygenase (decycling) 1 |
NM_002133 |
1.25 |
2.21 |
1.77 |
0.66 |
1.25 |
1.90 |
1.31 |
2.20 |
1.68 |
2.18 |
4.20 |
1.93 |
| biliverdin reductase B (flavin reductase (NADPH)) |
NM_000713 |
1.07 |
1.65 |
1.55 |
0.84 |
0.86 |
1.03 |
0.87 |
1.58 |
1.81 |
1.36 |
4.03 |
2.97 |
| sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA) -preferring, member 1 |
NM_003167 |
2.61 |
2.86 |
1.10 |
0.70 |
2.08 |
2.98 |
0.95 |
1.76 |
1.85 |
1.71 |
1.68 |
0.98 |
| abhydrolase domain containing 3 |
NM_138340 |
1.68 |
3.51 |
2.08 |
0.54 |
2.16 |
3.96 |
1.76 |
3.30 |
1.88 |
2.01 |
3.99 |
1.99 |
Tachibana et al. Nuclear Receptor 2005 3:3 doi:10.1186/1478-1336-3-3 |
|||||||||||||